

NEJM Interviews
NEJM Group
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
Episodes
Mentioned books

Dec 17, 2025 • 8min
NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.
Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.

Dec 10, 2025 • 10min
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.
Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.

Dec 3, 2025 • 15min
NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.
Robert Huckman, a Harvard Business School professor and health care expert, dives into the complexities of business models aimed at keeping people healthy. He discusses how current payment incentives favor procedures over health outcomes, leading to a misalignment in goals. Huckman examines the challenges digital and chronic-care ventures face in securing funding for preventive services. He highlights the importance of social determinants, data sharing, and the need for innovative partnerships to create sustainable, health-focused business models.

Nov 26, 2025 • 12min
NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.
Nishant Uppal, an instructor in medicine at Massachusetts General Hospital, discusses the rise of venture capital investments by academic medical centers. He highlights how financial pressures from COVID and rising costs are pushing these institutions to diversify. Uppal explains the structure of venture capital funds and notes that many AMCs are investing in unrelated companies. He raises concerns about unclear returns and calls for better oversight and policy responses to financial pressures affecting healthcare.

Nov 19, 2025 • 11min
NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine.
Jane Zhu, an associate professor at Oregon Health and Science University, discusses Oregon's groundbreaking SB 951 law aiming to reduce corporate control in healthcare. She highlights concerns over the rapid corporatization of medical practices and the influence of profit motives on patient care. Zhu details the law's restrictions on management service organizations and operational control tied to corporate ownership. While supporters believe it safeguards physician autonomy, she acknowledges criticisms regarding potential risks for small practices and advises additional measures to curb hospital consolidation.

Nov 12, 2025 • 13min
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.
Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Prevention Centers. N Engl J Med 2025;393:1867-1869.

Nov 5, 2025 • 8min
NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization.
Yashaswini Singh is an assistant professor of health services, policy, and practice at Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Singh. The Antitrust Antidote to Hospital and Nursing Home Corporatization — Promises and Pitfalls. N Engl J Med 2025;393:1761-1764.

Oct 22, 2025 • 10min
NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease.
Eberechi Nwogu-Onyemkpa is an assistant professor in the Division of Palliative Medicine at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Nwogu-Onyemkpa and Others. Involving Palliative Care to Improve Outcomes in Sickle Cell Disease. N Engl J Med 2025;393:1553-1556. E. Costa and Others. Thirty Years of Hydroxyurea for Sickle Cell Anemia — Scientific Progress, Global Health Gaps. N Engl J Med 2025;393:1556-1559.

Oct 15, 2025 • 10min
NEJM Interview: Michael Liu on a new model that will expand the use of prior authorization in traditional Medicare.
Michael Liu is a resident physician at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Liu, K.T. Kadakia, and R.K. Wadhera. Proliferation of Prior Authorization in Traditional Medicare — None the WISeR? N Engl J Med 2025;393:1457-1459.

Oct 8, 2025 • 6min
NEJM Interview: Andrew Gabrielson on cuts to the U.S. research agency charged with safeguarding workers’ health.
Andrew Gabrielson is a pediatric urology fellow at Lurie Children's Hospital of Chicago. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.T. Gabrielson and C. Corwin. Occupational Health and Safety on the Chopping Block — What’s at Stake? N Engl J Med 2025;393:1353-1355.


